Latest News about biotech
Recent news which mentions biotech
Bristol Myers Squibb Scoops Up Schizophrenia Player Karuna Therapeutics In Massive $14B Deal
December 22, 2023
From Benzinga
Jazz Pharmaceuticals' Post-Traumatic Stress Disorder Drug Disappoints In Mid-Stage Study
December 22, 2023
From Benzinga
Small-Cap Cancer Focused Theseus Pharmaceuticals Goes Private For Over $3.90/Share In Cash
December 22, 2023
From Benzinga
Fake Ozempic - FDA and Novo Nordisk Warn Against Counterfeit Ozempic Penetrating US Market Amid High Demand
December 22, 2023
From Benzinga
New Hope for Nerve Damage Patients as AstraZeneca/Ionis' Eplontersen Receives FDA Nod for Hereditary Amyloidosis Treatment
December 22, 2023
From Benzinga
Inebriation Remedy And Breakthrough MS Treatment: Meet FSD Pharma
December 21, 2023
Tickers
HUGE
From Benzinga
Argenx's Autoimmune Trial Stumble: Analysts Cut Price Targets, Warn of Risky Outcomes
December 21, 2023
Tickers
ARGX
From Benzinga
FDA Refuses Neurology-Focused Clene's Accelerated Approval For Amyotrophic Lateral Sclerosis Treatment, Shares Fall
December 21, 2023
Tickers
CLNN
From Benzinga
New Hope In Cancer Battle: FDA Grants Breakthrough Device Status To Vivos Inc.'s RadioGel
December 21, 2023
Tickers
RDGL
From Benzinga
From Benzinga
Why Is Complement-Mediated Focused Annexon Stock Trading Higher Today?
December 21, 2023
From Benzinga
Why Is Immunotherapy-Focused Hookipa Pharma Stock Soaring Today?
December 21, 2023
From Benzinga
Autoimmune Disease Player Immunovant's Investigational Drug For Immune System Disorder Shows Response Rates Of Over 50%
December 21, 2023
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.